Current and historical daily PE Ratio for BGMD (
BG Medicine Inc
) from 2011 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. BG Medicine stock (BGMD) PE ratio as of Apr 27 2024 is 0.
More Details
BG Medicine Inc (BGMD) PE Ratio (TTM) Chart
BG Medicine Inc (BGMD) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 0
- 1
| BG Medicine PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
BG Medicine Inc (BGMD) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
BG Medicine Inc
NAICS : 621511
SIC : 2835
ISIN : US08861T2069
Compare
Compare
Traded in other countries / regions
RBM1.GermanyBGMD.USA IPO Date
2011-02-04Description
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers